Zoe H. Adams

Zoe H. Adams

Auto-generated profile, based on publicly available information

Zoe H. Adams

Cardiff School of Sport and Health Sciences Cardiff Metropolitan University Cardiff UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Hypertension
Verified
Journal Article
Closed access
PDF file
THThomas C. Hinton
Thomas C. Hinton
ZAZoe H. Adams
Zoe H. Adams
RBRichard P. Baker
Richard P. Baker
KHKatrina A. Hope
Katrina A. Hope
JPJulian F.R. Paton
Julian F.R. Paton
ANAngus K. Nightingale
Angus K. Nightingale
Hypertension among young people is common, affecting 1 in 8 adults aged between 20 and 40 years. This number is likely to increase with lifestyle behaviors and lowering of hypertension diagnostic thresholds. Early-life factors influence blood pressure (BP) although the mechanisms are unclear; BP tracks strongly within individuals from adolescence through to later life. Higher BP at a young age is associated with abnormalities on heart and brain imaging and increases the likelihood of cardiovascular events by middle age. However, diagnosis rates are lower, and treatment is often delayed in young people. This reflects the lack of high-quality evidence that lowering BP in young adults improves cardiovascular outcomes later in life. In this review, we evaluate the current evidence regarding the association between BP in young adult life and adverse cardiovascular outcomes later in life. Following this, we discuss which young people with raised BP should be investigated for secondary causes of hypertension. Third, we assess the current models to assess cardiovascular risk and show a lack of validation in the younger age group. Fourth, we evaluate the evidence for lifestyle interventions in this age group and demonstrate a lack of persistence in BP lowering once the initial intervention has been delivered. Fifth, we address the pros and cons of drug treatment for raised BP in young people. Finally, there are unique life events in young people, such as pregnancy, that require specific advice on management and treatment of BP.

9 December 2016 in Circulation Research
Verified
Journal Article
Closed access
PDF file
EWEsther A. H. Warnert
Esther A. H. Warnert
JRJonathan C.L. Rodrigues
Jonathan C.L. Rodrigues
ABAmy E. Burchell
Amy E. Burchell
SNSandra Neumann
Sandra Neumann
LRLaura E.K. Ratcliffe
Laura E.K. Ratcliffe
EHEmma C. Hart
Emma C. Hart
Rationale:: Data from animal models of hypertension indicate that high blood pressure may develop as a vital mechanism to maintain adequate blood flow to the brain. We propose that congenital vascular variants of the posterior cerebral circulation and cerebral hypoperfusion could partially explain the pathogenesis of essential hypertension, which remains enigmatic in 95% of patients. Objective:: To evaluate the role of the cerebral circulation in the pathophysiology of hypertension. Methods and Results:: We completed a series of retrospective and mechanistic case-control magnetic resonance imaging and physiological studies in normotensive and hypertensive humans (n=259). Interestingly, in humans with hypertension, we report a higher prevalence of congenital cerebrovascular variants; vertebral artery hypoplasia, and an incomplete posterior circle of Willis, which were coupled with increased cerebral vascular resistance, reduced cerebral blood flow, and a higher incidence of lacunar type infarcts. Causally, cerebral vascular resistance was elevated before the onset of hypertension and elevated sympathetic nerve activity (n=126). Interestingly, untreated hypertensive patients (n=20) had a cerebral blood flow similar to age-matched controls (n=28). However, participants receiving antihypertensive therapy (with blood pressure controlled below target levels) had reduced cerebral perfusion (n=19). Finally, elevated cerebral vascular resistance was a predictor of hypertension, suggesting that it may be a novel prognostic or diagnostic marker (n=126). Conclusions:: Our data indicate that congenital cerebrovascular variants in the posterior circulation and the associated cerebral hypoperfusion may be a factor in triggering hypertension. Therefore, lowering blood pressure may worsen cerebral perfusion in susceptible individuals.

1 December 2019 in Hypertension
Verified
Journal Article
Open access
PDF file
SNSandra Neumann
Sandra Neumann
ABAmy E. Burchell
Amy E. Burchell
JRJonathan C.L. Rodrigues
Jonathan C.L. Rodrigues
CLChristopher B. Lawton
Christopher B. Lawton
DBDaniel Burden
Daniel Burden
EHEmma C. Hart
Emma C. Hart
Hypertension is associated with raised cerebral vascular resistance and cerebrovascular remodeling. It is currently unclear whether the cerebral circulation can maintain cerebral blood flow (CBF) during reductions in cardiac output (CO) in hypertensive patients thereby avoiding hypoperfusion of the brain. We hypothesized that hypertension would impair the ability to effectively regulate CBF during simulated hypovolemia. In the present study, 39 participants (13 normotensive, 13 controlled, and 13 uncontrolled hypertensives; mean age±SD, 55±10 years) underwent lower body negative pressure (LBNP) at −20, −40, and −50 mmHg to decrease central blood volume. Phase-contrast MR angiography was used to measure flow in the basilar and internal carotid arteries, as well as the ascending aorta. CBF and CO decreased during LBNP ( P <0.0001). Heart rate increased during LBNP, reaching significance at −50 mmHg ( P <0.0001). There was no change in mean arterial pressure during LBNP ( P =0.3). All participants showed similar reductions in CBF ( P =0.3, between groups) and CO ( P =0.7, between groups) during LBNP. There was no difference in resting CBF between the groups ( P =0.36). In summary, during reductions in CO induced by hypovolemic stress, mean arterial pressure is maintained but CBF declines indicating that CBF is dependent on CO in middle-aged normotensive and hypertensive volunteers. Hypertension is not associated with impairments in the CBF response to reduced CO.

5 May 2025 in The Journal of Physiology
Verified
Journal Article
Open access
ZAZoe H. Adams
Zoe H. Adams
DBDanielle E. Berbrier
Danielle E. Berbrier
BSBrittany K. Schwende
Brittany K. Schwende
WHWill Huckins
Will Huckins
CRCory T. Richards
Cory T. Richards
RLRachel N Lord
Rachel N Lord
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in premenopausal females. The condition is associated with an increased prevalence of cardiovascular risk factors, including hypertension. Observational studies report that some blood pressure control mechanisms are altered in PCOS compared to controls (sympathetic nervous system activity, endothelial and vasodilator function, renin angiotensin aldosterone system activation), and that these impairments correlate with androgen hormone levels, which are chronically elevated in the condition. As such, hyperandrogenism is the proposed locus of origin for the link between PCOS and cardiovascular dysfunction, yet the underlying mechanisms remain poorly understood. Preclinical work has provided some insight into how androgens modulate blood pressure control in PCOS. However there are marked discrepancies between the effects of androgens in cellular and tissue studies versus in vivo animal and human PCOS studies. This may be related to the heterogeneity of the preclinical models and samples used in this research and whether preclinical work is modelling hyperandrogenism in physiologically relevant terms for PCOS. This review collates preclinical and clinical evidence to summarise what is known and what remains unknown about cardiovascular control mechanisms in PCOS. We examine aspects of blood pressure regulation that are altered in other hypertensive cohorts, presenting current evidence for a mechanistic role of androgens on these systems, while acknowledging the diverse experimental models and participant cohorts from which the results are derived. image

1 November 2023 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
ZAZoe H. Adams
Zoe H. Adams
HBHazel C. Blythe
Hazel C. Blythe
NCNisha Charkoudian
Nisha Charkoudian
TCTimothy B. Curry
Timothy B. Curry
MJMichael Joyner
Michael Joyner
EHEmma C. Hart
Emma C. Hart
The current study demonstrates that respiratory modulation of sympathetic nerve activity (SNA) is reduced in healthy postmenopausal (PMF) versus premenopausal females (YF). Furthermore, respiratory sympathetic modulation was negatively related to resting blood pressure in postmenopausal females, such that blood pressure was greater in individual with less modulation. Reduced respiratory sympathetic modulation may have implications for the autonomic control of blood pressure in aging postmenopausal females, by contributing to age-related sympathetic activation and reducing acute, respiratory-linked blood pressure variation.

30 March 2025 in The Journal of Physiology
Verified
Journal Article
Open access
THThomas Hinton
Thomas Hinton
KHKatrina Hope
Katrina Hope
ZAZoe Adams
Zoe Adams
LSLydia L. Simpson
Lydia L. Simpson
JPJulian F. R. Paton
Julian F. R. Paton
EHEmma C. Hart
Emma C. Hart
Despite reports of amplified carotid chemoreflex sensitivity to hypoxia in young adults with hypertension (<40 years), it is unclear whether this equates to a direct role of this reflex in maintaining high resting and exercise blood pressures (BP). The aim of this study was to examine whether tonic carotid chemoreflex activity contributes to high resting and exercise BP in young people with untreated hypertension compared to normotensives (NTN). In 14 NTN and 14 untreated hypertensives (HTN) (aged 27 ± 6 and 28 ± 5 years, respectively) the ventilatory and haemodynamic responses to hypoxia were measured using the transient hypoxic test at rest and during submaximal steady‐state upright cycle exercise (40%–50% ). A double‐blinded placebo‐controlled systemic infusion of low‐dose dopamine (2 mcg/kg/min) was used to inhibit the carotid chemoreflex and assess its tonic contribution to ventilation and BP at rest and submaximal exercise (mixed‐model ANOVA). The hypoxic ventilatory response (HVR) at rest and submaximal cycle exercise were comparable between groups and were similarly blunted by dopamine infusion in both groups. However, at rest, there was a greater decrease in resting systolic BP (SBP) during carotid chemoreflex inhibition in the HTN group. Notably, during submaximal exercise, SBP was reduced during dopamine versus that during saline, but the decrease was similar between groups. The carotid chemoreflex appears to contribute to resting SBP in young people with untreated HTN but does not play a role in exaggerated exercise BP responses in this group. image Key points: The role of the carotid chemoreflex in maintaining high resting and exercise blood pressures in young adults with untreated hypertension is unclear. Carotid chemoreflex sensitivity, assessed by the ventilatory response to hypoxia was similar between untreated young adults with hypertension (n = 14, age < 40 years) and age‐matched normotensives (n = 14). During normoxic rest, there was a reduction in SBP during carotid chemoreflex inhibition with low‐dose dopamine (2 mcg/kg/min; vs. saline) in people with hypertension which was not observed in the normotensive group. During submaximal cycle exercise, SBP was reduced during carotid chemoreflex inhibition, but this was similar between groups. These results suggest the carotid chemoreflex influences resting SBP in hypertensives but does not affect the exaggerated exercise BP response in this group.